journal article·2018-08-28

Radiation and Heat Improve the Delivery and Efficacy of Nanotherapeutics by Modulating Intratumoral Fluid Dynamics

Shawn Stapleton, Michael Dunne, Michael Milosevic, Charles W. Tran, Matthew J. Gold, Ali Vedadi, Trevor D. Mckee, Pamela S. Ohashi, Christine Allen, David A. Jaffray

ACS Nano· Volume 12· Issue 8
Publisher page

Abstract

Nanomedicine drug delivery systems are capable of transporting significant payloads to solid tumors. However, only a modest increase in antitumor efficacy relative to the standard of care has been observed. In this study, we demonstrate that a single dose of radiation or mild hyperthermia can substantially improve tumor uptake and distribution of nanotherapeutics, resulting in improved treatment efficacy. The delivery of nanomedicine was driven by a reduction in interstitial fluid pressure (IFP) and small perturbation of steady-state fluid flow. The transient effects on fluid dynamics in tumors with high IFP was also shown to dominate over immune cell endocytic capacity, another mechanism suspected of improving drug delivery. Furthermore, we demonstrate the specificity of this mechanism by showing that delivery of nanotherapeutics to low IFP tumors with high leukocyte infiltration does not benefit from pretreatment with radiation or heat. These results demonstrate that focusing on small perturbations to steady-state fluid dynamics, rather than large sustained effects or uncertain immune cell recruitment strategies, can impart a vulnerability to tumors with high IFP and enhance nanotherapeutic drug delivery and treatment efficacy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Cancer Immunotherapy and Biomarkers · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada

Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada

Department of Radiation Oncology, University of Toronto, Toronto, ON M5S 3E2, Canada

Department of Immunology, University of Toronto, Toronto, ON M5S 1A1, Canada

Techna Institute, University Health Network, Toronto, ON M5G 1L5, Canada

Funding

Canadian Institutes of Health Research · Terry Fox Research Institute · Natural Sciences and Engineering Research Council of Canada

References (72)

Show source-provided references
1. 10.1158/0008-5472.CAN-05-419910.1158/0008-5472.CAN-05-4199 ↗
2. 10.1016/j.jconrel.2014.03.05710.1016/j.jconrel.2014.03.057 ↗
3. 10.1093/annonc/mdh09710.1093/annonc/mdh097 ↗
4. 10.1016/j.jconrel.2015.04.00610.1016/j.jconrel.2015.04.006 ↗
5. Harrington K. J. · Clin. Cancer Res. · 2000 · 6 · 4939
6. 10.1371/journal.pone.008115710.1371/journal.pone.0081157 ↗
7. 10.1016/j.jconrel.2015.06.00810.1016/j.jconrel.2015.06.008 ↗
8. 10.1158/0008-5472.CAN-03-057610.1158/0008-5472.CAN-03-0576 ↗
9. 10.1016/j.jconrel.2006.10.03210.1016/j.jconrel.2006.10.032 ↗
10. 10.1038/sj.bjc.660456110.1038/sj.bjc.6604561 ↗
11. Huang S. K. · Cancer Res. · 1994 · 54 · 2186
12. 10.1158/0008-5472.CAN-07-159910.1158/0008-5472.CAN-07-1599 ↗
13. 10.1126/scitranslmed.aac652210.1126/scitranslmed.aac6522 ↗
14. 10.1016/j.addr.2016.05.02110.1016/j.addr.2016.05.021 ↗
15. 10.1038/nrc145610.1038/nrc1456 ↗
16. 10.1158/1078-0432.CCR-14-049310.1158/1078-0432.CCR-14-0493 ↗
17. 10.3109/08982104.2012.65528510.3109/08982104.2012.655285 ↗
18. 10.1146/annurev-chembioeng-061010-11430010.1146/annurev-chembioeng-061010-114300 ↗
19. 10.1038/nmat378010.1038/nmat3780 ↗
20. 10.1016/j.drudis.2006.07.00510.1016/j.drudis.2006.07.005 ↗
21. 10.1038/ncomms969210.1038/ncomms9692 ↗
22. Mayer L. D. · J. Pharmacol. Exp. Ther. · 1997 · 280 · 140610.1016/S0022-3565(24)36522-X ↗
23. 10.1007/s11095-008-9629-910.1007/s11095-008-9629-9 ↗
24. 10.1021/mp800234r10.1021/mp800234r ↗
25. 10.1016/j.ijrobp.2012.07.00510.1016/j.ijrobp.2012.07.005 ↗
26. Znati C. A. · Cancer Res. · 1996 · 56 · 964
27. Znati C. A. · Clin. Cancer Res. · 2003 · 9 · 5508
28. Leunig M. · Cancer Res. · 1992 · 52 · 487
29. 10.1016/j.ejps.2007.05.11310.1016/j.ejps.2007.05.113 ↗
30. 10.1016/j.jconrel.2015.11.02110.1016/j.jconrel.2015.11.021 ↗
31. Clogston J. D. · 2013 · 2510.1142/9789814390262_0002 ↗
32. Abraham S. A. · 2005 · 391 · 71
33. 10.1016/j.nucmedbio.2009.02.00410.1016/j.nucmedbio.2009.02.004 ↗
34. 10.1124/jpet.103.05341310.1124/jpet.103.053413 ↗
35. 10.1016/j.nano.2012.05.00110.1016/j.nano.2012.05.001 ↗
36. 10.1016/j.jconrel.2013.08.29610.1016/j.jconrel.2013.08.296 ↗
37. 10.1016/0360-3016(95)00110-K10.1016/0360-3016(95)00110-K ↗
38. 10.1038/nnano.2012.4510.1038/nnano.2012.45 ↗
39. 10.1038/nrc136710.1038/nrc1367 ↗
40. 10.1172/JCI4028310.1172/JCI40283 ↗
41. 10.3389/fphys.2013.0015710.3389/fphys.2013.00157 ↗
42. 10.3109/02656736.2014.96864010.3109/02656736.2014.968640 ↗
43. 10.1038/nri384310.1038/nri3843 ↗
44. Netti P. A. · Cancer Res. · 1995 · 55 · 5451
45. 10.1073/pnas.061166010410.1073/pnas.0611660104 ↗
46. 10.1111/j.1349-7006.2008.01003.x10.1111/j.1349-7006.2008.01003.x ↗
47. 10.1038/nnano.2011.16610.1038/nnano.2011.166 ↗
48. 10.1016/j.jconrel.2013.01.02610.1016/j.jconrel.2013.01.026 ↗
49. 10.1021/acs.molpharmaceut.6b0046510.1021/acs.molpharmaceut.6b00465 ↗
50. Kong G. · Cancer Res. · 2001 · 61 · 3027
51. 10.1023/A:100752143023610.1023/A:1007521430236 ↗
52. 10.1158/1078-0432.CCR-13-012810.1158/1078-0432.CCR-13-0128 ↗
53. 10.1073/pnas.121335310910.1073/pnas.1213353109 ↗
54. 10.1016/j.nano.2017.08.01310.1016/j.nano.2017.08.013 ↗
55. 10.1126/scitranslmed.aal022510.1126/scitranslmed.aal0225 ↗
56. 10.1200/JCO.1999.17.11.351210.1200/JCO.1999.17.11.3512 ↗
57. 10.1038/sj.bjc.660048610.1038/sj.bjc.6600486 ↗
58. 10.1097/01.coc.0000182440.11653.5f10.1097/01.coc.0000182440.11653.5f ↗
59. 10.3892/or.12.2.47310.3892/or.12.2.473 ↗
60. Tsoutsou P. G. · Anticancer Res. · 2008 · 28 · 1349
61. 10.1023/A:101620173236810.1023/A:1016201732368 ↗
62. 10.1097/01.coc.0000224494.07907.4e10.1097/01.coc.0000224494.07907.4e ↗
63. 10.1080/02841860043078910.1080/028418600430789 ↗
64. Group E. B. C. T. C. · Lancet · 2006 · 366 · 2087
65. 10.1007/s12282-010-0206-910.1007/s12282-010-0206-9 ↗
66. 10.1016/j.radonc.2006.04.00610.1016/j.radonc.2006.04.006 ↗
67. 10.4155/tde.12.14710.4155/tde.12.147 ↗
68. 10.1016/j.jconrel.2014.01.00910.1016/j.jconrel.2014.01.009 ↗
69. 10.1186/gb-2006-7-10-r10010.1186/gb-2006-7-10-r100 ↗
70. Rasband W. · Astrophysics Source Code Library · 2012 · 1 · 06013
71. 10.1016/0026-2862(89)90074-510.1016/0026-2862(89)90074-5 ↗
72. 10.1038/psp.2012.1610.1038/psp.2012.16 ↗